JP2020528462A - 片頭痛の予防及び治療に使用するための栄養補助食品 - Google Patents

片頭痛の予防及び治療に使用するための栄養補助食品 Download PDF

Info

Publication number
JP2020528462A
JP2020528462A JP2020526709A JP2020526709A JP2020528462A JP 2020528462 A JP2020528462 A JP 2020528462A JP 2020526709 A JP2020526709 A JP 2020526709A JP 2020526709 A JP2020526709 A JP 2020526709A JP 2020528462 A JP2020528462 A JP 2020528462A
Authority
JP
Japan
Prior art keywords
extract
magnesium
weight
migraine
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2020526709A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020528462A5 (https=
Inventor
クリスティーナ デル ボーノ マリア
クリスティーナ デル ボーノ マリア
ボノーモ フランチェスコ
ボノーモ フランチェスコ
Original Assignee
クリスタルファルマ ソチエタ レスポンサビリタ リミタータ
クリスタルファルマ ソチエタ レスポンサビリタ リミタータ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by クリスタルファルマ ソチエタ レスポンサビリタ リミタータ, クリスタルファルマ ソチエタ レスポンサビリタ リミタータ filed Critical クリスタルファルマ ソチエタ レスポンサビリタ リミタータ
Publication of JP2020528462A publication Critical patent/JP2020528462A/ja
Publication of JP2020528462A5 publication Critical patent/JP2020528462A5/ja
Priority to JP2024025829A priority Critical patent/JP2024061731A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/76—Salicaceae (Willow family), e.g. poplar
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Inorganic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2020526709A 2017-07-26 2018-07-23 片頭痛の予防及び治療に使用するための栄養補助食品 Withdrawn JP2020528462A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024025829A JP2024061731A (ja) 2017-07-26 2024-02-22 片頭痛の予防及び治療に使用するための栄養補助食品

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102017000085185A IT201700085185A1 (it) 2017-07-26 2017-07-26 Integratore alimentare per uso come coadiuvante nel trattamento e profilassi dell’emicrania
IT102017000085185 2017-07-26
PCT/IB2018/055454 WO2019021148A1 (en) 2017-07-26 2018-07-23 FOOD SUPPLEMENTS FOR USE IN THE PROPHYLAXIS AND TREATMENT OF MIGRAINE

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024025829A Division JP2024061731A (ja) 2017-07-26 2024-02-22 片頭痛の予防及び治療に使用するための栄養補助食品

Publications (2)

Publication Number Publication Date
JP2020528462A true JP2020528462A (ja) 2020-09-24
JP2020528462A5 JP2020528462A5 (https=) 2021-09-02

Family

ID=60451071

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020526709A Withdrawn JP2020528462A (ja) 2017-07-26 2018-07-23 片頭痛の予防及び治療に使用するための栄養補助食品
JP2024025829A Pending JP2024061731A (ja) 2017-07-26 2024-02-22 片頭痛の予防及び治療に使用するための栄養補助食品

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024025829A Pending JP2024061731A (ja) 2017-07-26 2024-02-22 片頭痛の予防及び治療に使用するための栄養補助食品

Country Status (12)

Country Link
US (1) US11458160B2 (https=)
EP (1) EP3657964B1 (https=)
JP (2) JP2020528462A (https=)
CN (2) CN118203111A (https=)
CA (1) CA3069285A1 (https=)
DK (1) DK3657964T3 (https=)
ES (1) ES2917975T3 (https=)
HU (1) HUE059251T2 (https=)
IT (1) IT201700085185A1 (https=)
PL (1) PL3657964T3 (https=)
PT (1) PT3657964T (https=)
WO (1) WO2019021148A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023086266A (ja) * 2021-12-10 2023-06-22 日本メナード化粧品株式会社 血流改善剤
JP2023135861A (ja) * 2022-03-16 2023-09-29 味の素株式会社 塩味増強用組成物

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10512573A (ja) * 1995-01-26 1998-12-02 アシュベリー リサーチ コーポレーション セスキテルペンラクトンとビタミンｂ複合体とを含む片頭痛およびその他の疾病治療用複合剤
JP2001513803A (ja) * 1997-03-03 2001-09-04 ラボラトワール ルミレア 植物抽出物組成物、その製造方法、及びそれを含む医薬組成物
US6312736B1 (en) * 1999-12-09 2001-11-06 Biotech Corporation Herbal composition to relieve pain
JP2002518456A (ja) * 1998-06-25 2002-06-25 カート・ヘンドリクス 脳血管の正常状態を支持するための栄養補助食品
US20050036952A1 (en) * 2001-10-01 2005-02-17 Naturewell, Incorporated, A Corporation Compositions and methods for the treatment of aches and pains
US20140105878A1 (en) * 2009-05-06 2014-04-17 Kevin J. Kelleher Compositions and methods for prevention and treatment of migraines
US20150238524A1 (en) * 2011-07-25 2015-08-27 Donald J. Greene Composition and method for treating migraines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080206360A1 (en) * 2004-12-01 2008-08-28 Curt Hendrix Folate based migraine treatment
US20060233892A1 (en) * 2005-04-19 2006-10-19 Curt Hendrix Topiramate compositions for treatment of headache
CN101156935A (zh) * 2007-03-12 2008-04-09 北京联合伟华药业有限公司 治疗偏头痛的植物活性成分组合物及其制备方法和应用

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10512573A (ja) * 1995-01-26 1998-12-02 アシュベリー リサーチ コーポレーション セスキテルペンラクトンとビタミンｂ複合体とを含む片頭痛およびその他の疾病治療用複合剤
JP2001513803A (ja) * 1997-03-03 2001-09-04 ラボラトワール ルミレア 植物抽出物組成物、その製造方法、及びそれを含む医薬組成物
JP2002518456A (ja) * 1998-06-25 2002-06-25 カート・ヘンドリクス 脳血管の正常状態を支持するための栄養補助食品
US6312736B1 (en) * 1999-12-09 2001-11-06 Biotech Corporation Herbal composition to relieve pain
US20050036952A1 (en) * 2001-10-01 2005-02-17 Naturewell, Incorporated, A Corporation Compositions and methods for the treatment of aches and pains
US20140105878A1 (en) * 2009-05-06 2014-04-17 Kevin J. Kelleher Compositions and methods for prevention and treatment of migraines
US20150238524A1 (en) * 2011-07-25 2015-08-27 Donald J. Greene Composition and method for treating migraines

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "MIGRAWAY - FOR LONG TERM MIGRAINE & TENSION HEADACHE RELIEF", ELIXIR NATURALS, JPN5020009095, 2016, ISSN: 0004977558 *
CLIN DRUG INVEST., 2006, VOL.26 NO.5, P.287-296, JPN6022015423, ISSN: 0004977559 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023086266A (ja) * 2021-12-10 2023-06-22 日本メナード化粧品株式会社 血流改善剤
JP2023135861A (ja) * 2022-03-16 2023-09-29 味の素株式会社 塩味増強用組成物

Also Published As

Publication number Publication date
EP3657964B1 (en) 2022-04-20
US20200147130A1 (en) 2020-05-14
DK3657964T3 (da) 2022-06-20
EP3657964A1 (en) 2020-06-03
ES2917975T3 (es) 2022-07-12
US11458160B2 (en) 2022-10-04
WO2019021148A1 (en) 2019-01-31
CN118203111A (zh) 2024-06-18
CA3069285A1 (en) 2019-01-31
PL3657964T3 (pl) 2022-08-22
IT201700085185A1 (it) 2019-01-26
PT3657964T (pt) 2022-06-27
JP2024061731A (ja) 2024-05-08
HUE059251T2 (hu) 2022-11-28
CN111031814A (zh) 2020-04-17

Similar Documents

Publication Publication Date Title
US6793942B2 (en) Composition and method for treating the effects of diseases and maladies
US10272091B2 (en) Theacrine-based supplement and method of use thereof
US6841544B2 (en) Composition and method for treating the effects of diseases and maladies
US6787164B2 (en) Composition and method for treating the effects of diseases and maladies
CN108884053B (zh) 预防和/或治疗与衰老有关的认知障碍和神经炎症的方法
Auvinet et al. Comparison of the onset and intensity of action of intramuscular meloxicam and oral meloxicam in patients in acute sciatica
US8343554B2 (en) Formulations for the treatment of arthritis conditions
JP2002518456A (ja) 脳血管の正常状態を支持するための栄養補助食品
AU2018337933A1 (en) Synthetic transdermal cannabidiol for the treatment of focal epilepsy in adults
JP2024061731A (ja) 片頭痛の予防及び治療に使用するための栄養補助食品
US20010044411A1 (en) Composition and method for treating the effects of diseases and maladies
KR20140121475A (ko) 특발성 염증성 근질환의 예방 또는 치료제
HU228989B1 (en) Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
ITMI972690A1 (it) Uso di complessi di estratti vitis vinifera con fosfolipidi come agenti anti-arteriosclerotici
Fava et al. Efficacy of adjunctive cariprazine on anxiety symptoms in patients with major depressive disorder: post hoc analysis of a randomized placebo-controlled trial
US20030125303A1 (en) Transdermal formulation for repair and maintenance of connective tissue
CN105106520A (zh) 一种保健品
US20050043274A1 (en) Pharmaceutical compositions and methods for lowering blood pressure and pulse rate
US20110117070A1 (en) Compositions and methods for treating headache
KR102927058B1 (ko) 진통 가려움 완화 약학 조성물 및 그 응용 방법
CN103635194B (zh) 用于治疗早泄的药物组合物以及用于治疗早泄的方法
US20010043959A1 (en) Composition and method for treating the effects of diseases and maladies
HK40029032B (en) Food supplements for use in the prophylaxis and treatment of migraine
HK40029032A (en) Food supplements for use in the prophylaxis and treatment of migraine
JP2017066143A (ja) 止瀉剤組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210719

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210719

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220420

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220420

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220704

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221019

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230131

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230427

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20231024

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20240227

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20240723